Bibliografia UJ CM

1/10
Stijn A. Peeters, Lian Engelen, Jacqueline Buijs, Nish Chaturvedi, John H. Fuller, Casper G. Schalkwijk, Coen D. Stehouwer, EURODIAB Prospective Complications Study Group.
Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study.
Cardiovascular Diabetology
2015 : Vol. 14, art. no. 31, il., bibliogr. 42 poz., abstr.
Open Access Creative Commons Attribution License CC-BY 4.0.
p-ISSN: 1475-2840
AZ
ORG
AIF
IF: 4.534
Streszczenie w PubMed:
Repozytorium UJ CM:
2/10
Sabita S. Soedamah-Muthu, Nish Chaturvedi, John H. Fuller, Monika Toeller, EURODIAB Prospective Complications Study Group.
Do European people with type 1 diabetes consume a high atherogenic diet? 7-year follow-up of the EURODIAB Prospective Complications Study.
European Journal of Nutrition
2013 : Vol. 52, nr 7, s. 1701-1710, il., bibliogr. 49 poz., abstr.
p-ISSN: 1436-6207
AZ
ORG
AIF
IF: 3.840
Adres url:
Streszczenie w PubMed:
3/10
Johanna W.M. Nin, Isabel Ferreira, Casper G. Schalkwijk, Martin H Prins, Nish Chaturvedi, John H. Fuller, Coen D.A. Stehouwer, EURODIAB Prospective Complications Study Group.
Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study.
European Journal of Endocrinology
2012 : Vol. 166, nr 2, s. 325-332, il., bibliogr. 42 poz., abstr.
p-ISSN: 0804-4643
AZ
ORG
AIF
IF: 3.360
Adres url:
Streszczenie w PubMed:
4/10
Nish Chaturvedi, Massimo Porta, Ronald Klein, Trevor Orchard, John Fuller, Hans Henrik Parving, Rudy Bilous, Anne Katrin Sjolie, DIRECT Programme Study Group.
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes : randomised, placebo-controlled trials.
Lancet
2008 : Vol. 372, nr 9647, s. 1394-1402, il., bibliogr. 34 poz., summ.
p-ISSN: 0140-6736
AZ
ORG
AIF
IF: 28.409
5/10
Anne Katrin Sjolie, Ronald Klein, Massimo Porta, Trevor Orchard, John Fuller, Hans Henrik Parving, Rudy Bilous, Nish Chaturvedi, DIRECT Programme Study Group.
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2) : a randomised placebo-controlled trial.
Lancet
2008 : Vol. 372, nr 9647, s. 1385-1393, il., bibliogr. 48 poz., summ.
p-ISSN: 0140-6736
AZ
ORG
AIF
IF: 28.409
6/10
Sabita S. Soedamah-Muthu, Nish Chaturvedi, Daniel R. Witte, Lynda K. Stevens, Massimo Porta, John Fuller, EURODIAB Prospective Complications Group.
Relationship between risk factors and mortality in type 1 diabetic patients in Europe : the EURODIAB Prospective Complications Study (PCS).
Diabetes Care
2008 : Vol. 31, nr 7, s. 1360-1366, bibliogr. 26 poz.
p-ISSN: 0149-5992
AZ
ORG
AIF
IF: 7.349
7/10
Nish Chaturvedi, Anne-Katrin Sjolie, Massimo Porta, Steven J. Aldington, John H. Fuller, Marco Songini, Eva M. Kohner, PCS Group The EURODIAB.
Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes.
Diabetes Care
2001 : Vol. 24, nr 2, s. 284-289, il., bibliogr. 45 poz.
AZ
ORG
AIF
IF: 5.404
8/10
Martin A. Crook, John C. Pickup, Peter J. Lumb, Francesco Georgino, David J. Webb, John H. Fuller, PCS Group The EURODIAB.
Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes.
Diabetes Care
2001 : Vol. 24, nr 2, s. 316-322, il., bibliogr. 41 poz.
AZ
ORG
AIF
IF: 5.404
9/10
S.S. Soedamah-Muthu, H.M. Colhoun, M.R. Taskinen, B[arbara] Idzior-Walus, J[ohn] H. Fuller, The EURODIAB IDDM Complications Study Group.
Differences in HDL-cholesterol : apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in type I diabetic patients.
Diabetologia
2000 : Vol. 43, nr 11, s. 1353-1359, bibliogr. 40 poz., abstr.
AZ
ORG
AIF
IF: 5.721
10/10
Nishi Chaturvedi, Judith M. Stephenson, John H. Fuller, The EURODIAB IDDM Complications Study Group.
The relationship between smoking and microvascular complications in the EURODIAB IDDM complications study.
Diabetes Care
1995 : Vol. 18, nr 6, s. 785-792, bibliogr. 31 poz.
p-ISSN: 0149-5992
e-ISSN: 1935-5548
AZ
ORG
AIF
IF: 2.525
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ